The prolactin secretory response to neuroleptic drugs: Mechanisms, applications and limitations
- 31 December 1980
- journal article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 5 (2), 121-137
- https://doi.org/10.1016/0306-4530(80)90015-3
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Thyrotropin releasing hormone (TRH) is not the physiological prolactin releasing factor (PRF) in the male ratLife Sciences, 1978
- Localization of the site of the haloperidol-induced, prolactin-mediated increase of dopamine turnover in the median eminence: Studies in rats with complete hypothalamic deafferentationsJournal of Neural Transmission, 1978
- A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptorsLife Sciences, 1978
- Prolactin in CSF selectively increases dopamine turnover in the median eminenceLife Sciences, 1978
- Relationship between prolactin response and antipsychotic effect of thioridazine in psychiatric patientsEuropean Journal of Clinical Pharmacology, 1978
- Plasma Level Monitoring of Antipsychotic DrugsClinical Pharmacokinetics, 1978
- Enhanced prolactin inhibition following chronic treatment with haloperidol and morphineLife Sciences, 1977
- Clozapine increases rat serum prolactin levelsLife Sciences, 1975
- Effects of Haloperidol on Serum and Pituitary Prolactin, LH and FSH, and Hypothalamic PIF and LRFNeuroendocrinology, 1974
- Thyrotropin releasing hormone: Direct evidence for stimulation of prolactin production by pituitary cells in cultureBiochemical and Biophysical Research Communications, 1971